Infectious disease: the human costs of our environmental errors. by Weinhold, Bob
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or a few exhilarating decades in the middle of
the twentieth century, it seemed the world
might have a reprieve from some major infec-
tious diseases. After coordinated worldwide efforts had
virtually eliminated smallpox and made major inroads
against other infectious diseases such as influenza,
tuberculosis, and polio, some public health officials
thought we had entered a new era in which infectious
diseases would no longer be among the planet’s worst
killers. By the 1980s, though, those hopes were dashed,
due in large part to the burgeoning AIDS epidemic. 
Beginning around the same time, dozens of other
infectious diseases—including Lyme disease, han-
tavirus pulmonary syndrome, West Nile virus, and Ebola hemorrhagic
fever—were either newly recognized, spread to new locations, or became
increasingly deadly. In 2003 alone, SARS, avian influenza, and monkeypox
were among the infectious news makers. Along with
the “new” diseases, long-time threats such as malaria
surged back, now killing about 3 million people
each year and infecting at least 300 million more,
according to the 2002 U.S. National Institute of
Allergy and Infectious Diseases (NIAID) publica-
tion Microbes: In Sickness and in Health.
More  than a dozen major factors have been
pegged over the past 10–15 years as existing or
potential contributors to infectious disease out-
breaks. Microbes continue to evolve rapidly, and
Focus | Infectious Diseasehuman susceptibility to infection is increas-
ing due to malnutrition, weakening of
immune systems through cancer treatments
or chronic diseases, and aging of the popu-
lation in some countries. Extensive poverty
and population growth have spawned
impacts such as poor basic public health
infrastructure in megacities. Wars result in
dislocation of peoples, destruction of pub-
lic health systems, malnutrition, and intro-
duction of new microbes by soldiers return-
ing home; bioterrorism raises the possibili-
ty of infectious agents being released upon
the population at large. Changing medical
technology allows exchanges of microbes
through blood transfusions and organ and
tissue transplants, some of which come
from animals. Increased international trav-
el and exchange of goods—including ani-
mals, plants, and foods that can carry
pathogens—both spread diseases rapidly.
Many nations have seen reduced funding
for safe water and sewer systems, vaccines,
research, surveillance, prevention, and
response, due in part to complacency. 
As if those driving forces weren’t enough
to contend with, many environmental fac-
tors are playing major roles, including cli-
mate change, deforestation, global dust
transport, and numerous agricultural prac-
tices. The links between these factors and
millions of potential human deaths have
often been overlooked or discounted as pol-
lution and other more obvious concerns
have typically drawn the limelight.
Emerging and Surging
The complex relationship between people
and microbes has been evolving for tens of
thousands of years. Many microbes are
essential to our health. But a few bacteria
and many viruses, fungi, and protozoa can
cause infectious diseases and play a role in
cancers, coronary heart disease, diabetes,
multiple sclerosis, autism,
and chronic lung diseases.
With the accelerated
development of vaccines
and antibiotics in the
past century, along with
major regional and
worldwide drives to use
these new tools, some of
the worst offenders have
been beaten back.
Smallpox, for example,
which some researchers
say at one time had killed
more people than all
other infectious diseases
combined, was virtually
eliminated in 1977
thanks to a global vacci-
nation effort. Along with
the success against smallpox came strides
against polio, malaria, measles, guinea
worm disease, and other nemeses. 
More  than 1,400 species of infectious
microbes are known to be human
pathogens, and of these, 175 fall into the
“emerging” category, wrote Louise H. Taylor
and colleagues from the U.K. Centre for
Tropical Veterinary Medicine in the 29 July
2001 issue of Philosophical Transactions:
Biological Sciences. Of the total 1,400-plus
species, 61% are zoonotic, meaning they can
be passed from animals to people, and about
75% of the emerging species are zoonotic.
Viruses and protozoa are among the most
likely to be considered “emerging.” 
Stephanie Schrag, an epidemiologist
with the Centers for Disease Control and
Prevention (CDC), says estimates of the
number of emerging infectious diseases can
vary because there’s no universal agreement
on exactly what constitutes an emerging or
re-emerging disease. In general, emergence
has been tied to substantial increases in
mortality and morbidity, but there are no
strict thresholds for when a disease is con-
sidered emerging, and problems around the
world with data quality compound the
problem. However, Schrag says, a precise
number isn’t the most important issue. “It
only takes one [outbreak] to have a serious
global problem,” she says. 
Costly Killers
In the United States, efforts against infec-
tious disease have led to huge reductions in
resulting deaths, with rates in 1980 less
than 5% what they were in 1900, according
to an analysis published by Gregory
Armstrong and colleagues from the CDC
in the 6 January 1999 Journal of the
American Medical Association. Other devel-
oped countries have seen similar progress,
and some developing nations have had spo-
radic successes. 
The downside of that progress has been
widespread complacency, says Randall
Culpepper, director of overseas operations
for the U.S. Department of Defense’s
Global Emerging Infections Surveillance
and Response System. Although some such
relaxed vigilance is evident on the part of
health workers and the public, perhaps
most important has been complacency
among politicians who fund public health
efforts. As a result, funding for a variety of
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A host of hosts. Urban migration and dense populations offer
the perfect environment for the spread of microbial pathogens.
No refuge. Civilians in south Sudan flee that country’s civil war, now in its twentieth year. In addi-
tion to dislocating people, wars destroy health infrastructure and create conditions ripe for illness. Environmental Health Perspectives • VOLUME 112 | NUMBER 1 | January 2004 A 35
public health programs was cut starting in
the 1980s, disease surveillance was reduced,
and efforts shifted toward chronic diseases
such as cancer—although the U.S. death
rate for noninfectious diseases has barely
nudged downward since 1900.
Microbes needed only a few years to find
windows of vulnerability. Today, infectious
diseases are once again a cause for grave con-
cern, causing about one-quarter of the
world’s 55 million deaths each year, accord-
ing to the 1999 World Health Organization
(WHO) report Removing Obstacles to
Healthy Development. They trail only cardio-
vascular disease in terms of
causing death, and are
responsible for twice as
many deaths as cancers.
About 90% of infectious
disease deaths are caused
by acute respiratory infec-
tions (such as influenza
and pneumonia), diarrheal
diseases, tuberculosis, ma-
laria, measles, hepatitis B,
and HIV/AIDS. More
than 40 million people
have been infected with
HIV worldwide, for exam-
ple; more than 20 million
people have died of
HIV/AIDS in just 20
years, and another 45 mil-
lion are expected to
become infected by 2010,
according to the WHO.
Various estimates put
AIDS as the second to
fourth leading cause of
death worldwide.
In developed countries, the percentages
of infectious disease deaths tend to be much
lower than the average, though they too
have risen in the past few decades. In the
United States the rate has approximately
doubled since 1980, to about 170,000 peo-
ple per year, said the U.S. Central
Intelligence Agency’s National Intelligence
Council (NIC) in a 2000 report, The
Global Infectious Disease Threat and Its
Implications for the United States.
Costs from infectious diseases can be
substantial worldwide. The 2003 SARS
outbreak cost China and Canada about 1%
of their economies, primarily through lost
tourism and travel revenues, the NIC
reported in the August 2003 publication
SARS: Down But Still a Threat. In sub-
Saharan Africa, workforce havoc wrought
by  HIV/AIDS and malaria alone are
expected to reduce gross domestic product
by 20% or more by 2010, the NIC report-
ed in Global Infectious Disease Threat. In the
United Kingdom, cases of bovine spongi-
form encephalopathy and variant
Creutzfeldt-Jakob disease in 1995 led to
mass cattle slaughters and a three-year beef
embargo, costing the British economy
US$5.75 billion. Even the relatively low
number of U.S. infectious disease cases
costs more than $120 billion per year to
treat, noted the NIAID in Microbes: In
Sickness and in Health.
Conversely, prevention can be cost-
effective. Eradication of smallpox reduced
the global health bill by $20 billion, and the
$3 billion savings in the United States cost
a relatively paltry $32 million in preventive
measure investments, the CDC said in its
2002 report, Protecting the Nation’s Health
in an Era of Globalization: CDC’s Global
Infectious Disease Strategy. 
Beyond the lives lost and dollars spent,
infectious diseases have a number of other
costs, such as the breakdown of social struc-
ture. According to the Joint United Nations
Programme on HIV/AIDS, 14 million chil-
dren had lost one or both parents to
HIV/AIDS by the end of 2001, and the
NIC said in Global Infectious Disease Threat
that number will reach 42 million by 2010.
Emerging Environmental Factors
Many infectious disease deaths are linked
with environmental factors. The environ-
mental factor that affects perhaps the most
countries is climate change. Some infec-
tious diseases may change in tandem with
climate; among the primary suspects, based
on piecemeal evidence, are malaria, dengue
fever, cholera, and yellow fever. But exten-
sive, long-term evidence is scant so far. “It’s
very difficult to attribute disease change to
climate change,” cautions Jonathan Patz,
director of the Program on Health Effects
of Global Environmental Change at the
Johns Hopkins Bloomberg School of Public
Health. Usually there are at best only weak
long-term health data on potentially perti-
nent diseases, and many confounding fac-
tors—such as changes in pest control prac-
tices, travel patterns, and human settlement
densities and locations—make analysis
more difficult.
One significant exception to date, Patz
notes, is a linkage between cholera and the
El  Niño/Southern Os-
cillation (ENSO) in
Bangladesh from 1893
to 2001, as described
by  physical scientist
Xavier Rodó of the
University of Barcelona
and colleagues in the 1
October 2002 Proceed-
ings of the National
Academy of Sciences.
The team found that
ENSO, which causes
warmer-than-usual
equatorial Pacific Ocean
temperatures, was re-
sponsible for more than
70% of the variance in
cholera mortality and
morbidity, and that
ENSO was increasing
in both frequency and
intensity over time,
possibly in connection
with long-term ocean
warming trends. 
According to the 2003 WHO publica-
tion Climate Change and Human Health:
Risks and Responses, other clues are offered
by shorter-term evidence, such as links in
New Zealand between temperature rise and
salmonella infections, in the South Pacific
between La Niña (with its cooler-than-usual
equatorial Pacific Ocean temperatures) and
dengue fever incidence, and in many cli-
mates between rainfall and diarrheal dis-
eases such as shigellosis and cryptosporidio-
sis. The WHO concluded that climate
change may play a relatively small but
nonetheless very real role in the world’s
death totals, already killing more than
150,000 people per year, in part through
increases in infectious diseases. 
While much science remains to be
done, “climate stability is a crucial issue for
all aspects of society,” says Paul Epstein,
associate director of the Center for Health
and the Global Environment at Harvard
Medical School. “If we don’t get the solu-
tions right, all the other issues are moot.”
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Climate culprit. Long-term warming trends have been shown to encourage the spread
and worsen the impact of some infectious diseases.Another globe-encompassing factor is the
intercontinental transport of dust, which
arises from at least 10 major soil reservoirs on
five continents, according to EHP’s February
2002 Focus article (EHP 110:A80–A87
[2002]). In the 19 March 2003 Geophysical
Research Letters, scientists funded by the U.S.
National Aeronautics and Space
Administration documented some of the far-
thest transport yet, confirming that dust in
the French Alps had floated from China dur-
ing a two-week journey in 1990. 
Hundreds of millions of tons of dust
circle the world each year, wrote researchers
from the U.S. Geological Survey (USGS),
Florida International University, the
University of South Carolina, and the com-
pany Microgenomics in the May 2003 issue
of BioScience. And just 1 million tons of
dust may contain 10 quadrillion microbes,
the USGS noted in its January 2003 publi-
cation African Dust Carries Microbes Across
the Ocean: Are They Affecting Human and
Ecosystem Health? Many microbes are killed
in transport, but far more than expected
survive, researchers have found. 
Microbes in airborne dust known to be
pathogenic to people include those causing
plague, anthrax, tuberculosis, influenza,
hantavirus pulmonary syndrome, meningo-
coccal meningitis, coccidioidomycosis, and
aspergillosis. However, as yet there are no
proven links between airborne dust and
infectious disease outbreaks in people, says
Christina Kellogg, a USGS research micro-
biologist who contributed to the BioScience
paper.
At the local scale, land use changes trig-
gered as the world’s population rockets past
6.3 billion (up from 4 billion just 30 years
ago) are influencing infectious diseases.
Urbanization, road and dam construction,
deforestation, forest fires, and pollution can
all play a role in diseases such as Lyme dis-
ease, leishmaniasis, dengue fever, and schis-
tosomiasis.
Lyme disease, caused
by  the bacterium Borrelia
burgdorferi and transmitted
by  ticks from wildlife to
people, was first observed
in 1977 in Connecticut.
The generally nonfatal dis-
ease can be very painful,
causing symptoms such as
joint and muscle pain,
headache, fatigue, fever,
sleep disorders, and per-
sonality changes.
One important con-
tributing factor to Lyme
disease emergence is frag-
mentation of forest habitat,
says Richard Ostfeld, an
animal ecologist with the
Millbrook, New York–based
Institute of Ecosystem
Studies. In an article pub-
lished in the February 2003
issue of Conservation Biol-
ogy, he and his team found
that important Northeastern
tick host species such as
white-footed mice fared
better when forest tracts
were smaller than five acres,
and that the infection rate
of ticks was much higher in
the small tracts. When people lived next to
these tracts, the odds of human infection
rose substantially. 
In another study, published 21 January
2003 in Proceedings of the National
Academy of Sciences, Ostfeld and his team
confirmed that tick infection rates were
generally linked with species diversity—the
more species in a tract, the lower the over-
all tick infection rate. In their research
tracts in southeastern New York, they
found that it was most important to retain
squirrels and opossums, which can clear the
infection quickly and don’t pass it on to
other ticks. On the other hand, shrews and
white-footed mice proved to be very impor-
tant disease carriers. 
Animals play many other roles in trans-
mitting disease to humans as well.
“Humans are horribly susceptible to a wide
range of diseases from many animals,” says
William Karesh, head of the Wildlife
Conservation Society’s Field Veterinary
Program. Recent examples of diseases either
proven or strongly suspected of originating
with animals include HIV/AIDS, simian
immunodeficiency virus, SARS, monkey-
pox, and Ebola hemorrhagic fever. 
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Dirty dust. The global transport of dust carries microbes across
oceans and continents.
No where to go but out. Deforestation from logging and agri-
cultural practices leaves disease-carrying animals with no choice
but to migrate into human living areas.Environmental Health Perspectives • VOLUME 112 | NUMBER 1 | January 2004 A 37
The huge surge in international trade of
animals for uses such as pets or exotic cui-
sine may be the biggest concern from a
global perspective, Karesh says, because dis-
eases can be transported so rapidly and
widely. In the United States alone, such
trade has grown 62% in the past decade,
sparked in large part by the increase in dis-
posable income in the United States, as well
as easier travel, transport, and electronic
payment methods. 
This trade now involves 352,000
species, U.S. Fish and Wildlife Service
(FWS) deputy director Marshall Jones told
a Senate committee on 17 July 2003. Jones
testified that the 2002 U.S. traffic in live
animals  included 216 million fish, 49 mil-
lion amphibians, 2 million reptiles,
365,000 birds, and 38,000 mammals.
The CDC has found that potentially
fatal diseases such as monkeypox, sal-
monellosis, tularemia, and plague have
been transmitted to people via import-
ed animals such as squirrels, mice,
lizards, snakes, and turtles.
FWS inspectors attempt to moni-
tor this animal traffic, but with just 92
of them at 32 points of entry into the
country, they would have approxi-
mately three seconds to inspect each
animal if that’s all they did every
minute of every work day. And they
are not trained to detect diseases, but
rather to look out for endangered
species and ensure that animals are
being transported safely.
The responsibility for controlling
this traffic isn’t solely that of the FWS;
the U.S. Department of Agriculture,
the U.S. Food and Drug
Administration, and the CDC also
have roles. Mira Leslie, a public health
veterinarian with the Washington
State Department of Health, says
progress is being made incrementally,
as shown by the response to a
July 2003 position statement
by the Council of State and
Territorial Epidemiologists to
have these agencies, along
with the National
Association of State Public
Health Veterinarians, jointly
develop policies to regulate
this traffic. New regulations
to control monkeypox have
been implemented with
unprecedented speed, but so
far a more comprehensive
multiagency prevention and
control plan has not been
developed, Leslie says.
Local consumption of
indigenous animals also can
cause major problems, though possibly
more slowly. HIV/AIDS, thought to have
first been acquired from animals about a
half a century ago, has taken decades to
wreak its havoc. But with the speed of trav-
el now possible, many observers fear that
other diseases may take hold similarly, but
much more quickly. SARS (suspected of
being transmitted from animals such as
civet cats and ferret badgers) and diseases
strongly suspected to be common to both
people and some primates (including Ebola
hemorrhagic fever and simian immunodefi-
ciency virus) are examples of those that
worry many public health officials.
Domestic animals also can play a role
in the spread of infectious diseases. The
pathogenic bacterium  Escherichia coli
O157:H7, first recognized as a cause of ill-
ness in 1982, is clearly associated with cat-
tle, says Sheridan Haack, a USGS research
hydrologist studying the microbe, citing evi-
dence accumulated over the past two
decades. “Farmers who handle cattle, or oth-
ers who encounter cattle on a regular basis,
are at greater risk of acquiring the disease,”
she says. Also at risk are people who eat
inadequately cooked infected beef, which
typically includes about 25–40% of the ani-
mals sampled in feedlots, according to a
University of Nebraska study in the 2
January 2004 issue of Vaccine (although
tests with vaccines and beneficial bacteria
show those numbers can be cut by two-
thirds). About 10–15% of people affected
develop complications that can lead to kid-
ney failure and death. 
The construction of irrigation dams has
been linked with the spread of other dis-
eases. In a number of locations around the
world, such dams have increased the breed-
ing habitat for mosquitoes, resulting in
large increases in malaria over relatively
short periods of time, Patz says. For exam-
ple, a presentation at the 2002 colloquium
Unhealthy Landscapes: How Land Use
Change Affects Health, sponsored by the
WHO, the United Nations Environment
Programme, the NIH John E. Fogarty
International Center, and the NIEHS, cited
a sevenfold increase in Ethiopia following
dam construction. (These proceedings have
been submitted for publication in EHP.)
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We are what we eat. Diseases such as SARS are suspected of being transmitted to people through con-
sumption of indigenous animal meat such as the goods sold in this market in Guangdong Province, China.
Curiosity shops. Trade in exotic animals has increased in
recent years, increasing people’s exposure to infectious agents
formerly unknown to human populations.Focus | Infectious Disease
Dam building in Africa has also created
habitats that contribute to increased mos-
quito and snail populations and resulting
outbreaks of Rift Valley fever and schistoso-
miasis, respectively, the NIC said in Global
Infectious Disease Threat. 
Other agricultural practices can play a
role in the spread of infectious diseases. The
widespread use of antibiotics in animals is
of worldwide concern because of the role
such uses can play in the surge in antibiot-
ic resistance. The Institute of Medicine
(IOM) recommended in its 2003 report
Microbial Threats to Health: Emergence,
Detection, and Response that the Food and
Drug Administration should ban uses of
antibiotics for growth promotion in ani-
mals for any drug classes also used in peo-
ple. 
In the same report, the IOM warned
that many emerging infectious diseases are
linked with changing land use practices.
One of those practices is the spread of
sewage sludge and its associated pathogens.
In  the United States, the Environmental
Protection Agency’s standards for treated
sewage sludge are seriously outdated and
don’t adequately address health concerns,
asserted the National Research Council in
the 2 July 2002 report Biosolids Applied to
Land: Advancing Standards and Practices.
The IOM also cautioned that infectious
diseases are linked with “ecological changes
that can alter the replication and transmis-
sion patterns of pathogens.” One practice
that can substantially alter ecosystems is the
widespread use of hundreds of millions of
pounds of pesticide products. On the other
hand, the IOM recommended the use of
some pesticides to contol disease vectors.
Defensive Tactics
With threats from infectious diseases accel-
erated by so many factors, it’s impossible to
intervene quickly on all fronts. But some
experts have ideas about a
few overarching concepts
to consider.
In  an article in the
1998 book Pathology of
Emerging Infections 2,
Johns Hopkins interna-
tional health professor
Donald Burke wrote that
RNA viruses may be one
of the biggest concerns,
because they can mutate,
recombine, and cross
between species so rapid-
ly. Influenza, polio,
HIV/AIDS, and foot-
and-mouth disease are
caused by RNA viruses.
The research to date on
SARS indicates that it may be caused by
two types of viruses that Burke predicted
would be of great concern: coronaviruses
and reoviruses. The coronavirus may have
come from an extremely rare recombina-
tion of viruses from mammal and bird
hosts, wrote David Guttman, a University
of Toronto professor of evolutionary
genomics, in the January 2004 issue of the
Journal of Virology.
Schrag agrees that RNA viruses are a
serious threat. Influenza, for example, has
killed and continues to kill huge numbers
of people, including 20–40 million people
in 1918–1919. In recent years, about 3.5
million people have died annually from
acute respiratory infections, including
influenza and pneumonia. Influenza deaths
surge in fairly regular cycles. For instance,
there were about 70,000 U.S. deaths in
1957, about 34,000 in 1968 (when the
average was then about 20,000), and about
65,000 in 1999. The current average is
about 36,000, which some public health
officials fear will be greatly exceeded in
2004, due to the early and strong onset of
a strain called A/Fujian, which isn’t fully
protected for with the current vaccine. A
full pandemic might kill 89,000–207,000
people in the United States, wrote Maine
state epidemiologist Kathleen Gensheimer
and colleagues in the December 2003 issue
of Emerging Infectious Diseases.
Karesh has a little different take. He
suspects that the greatest threats may come
from those microbes that are generalists—
thriving in many settings and species—
because they are so widespread and so
adaptable to a range of conditions. The
microbes that cause tuberculosis, Nipah
virus encephalitis, rabies, salmonellosis,
herpes, and hantavirus pulmonary syn-
drome fall under that umbrella.
Patz says that it may be best to focus on
diseases that are being promoted by human
activity and that are therefore preventable.
In  that light, issues such as land use
changes, global warming, and international
travel and shipping may be very important.
As agencies worldwide struggle to cope
with infectious diseases, many have begun
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It’s a small world after all. Burgeoning global travel means that infectious disease outbreaks
are more likely to become a global—rather than local—phenomenon.
Making microbes meaner. Practices such as insecticide spraying
can lead to microbial resistance.piecemeal efforts to address some of the
threats, spending billions of dollars on sur-
veillance, mitigation, and treatment of spe-
cific diseases in the past few years alone.
The WHO established its Global Outbreak
Alert and Response Network in 2000,
drawing together basic information on a
handful of key infectious diseases (though
the agency is limited in what it can do in
response to outbreaks when they occur).
The SARS outbreak in 2003 led to better
coordination among many of the world’s
agencies. 
And disease control efforts have some-
times shown multiple benefits. For
instance, the slaughter and management of
farm animals in southern Scotland in
2001 in response to a foot-and-
mouth disease outbreak led in turn to
reduced human cases of cryp-
tosporidiosis, also linked with farm
animals, Norval J.C. Strachan of the
University of Aberdeen and col-
leagues reported in the 1 September
2003 Journal of Infectious Diseases. 
In  other signs of progress, the
fourth International Conference on
Emerging Infectious Diseases, begin-
ning 29 February 2004 in Atlanta,
likely will expand understanding of
infectious disease issues. A number of
agencies in the United States are
beginning to talk to each other a lit-
tle more, breaking down old bureau-
cratic and turf barriers, Karesh says.
The CDC is in the midst of updating
its strategic plan for coping with
emerging infectious diseases, and
researchers at agencies such as the
Environmental Protection Agency
and the Department of Agriculture
are developing models to predict out-
breaks of illnesses such as Lyme dis-
ease. Other researchers, funded
through the Ecology of Infectious
Diseases initiative sponsored by the
National Science Foundation, the
NIH, and the USGS, are investigat-
ing numerous links between human dis-
eases and the environment. 
Budgets of some of the agencies dealing
with infectious diseases have risen dramati-
cally over the past decade. For instance, the
CDC’s National Center for Infectious
Diseases has seen its emerging infectious
diseases national plan implementation
budget leap from $1 million in 1994 to
about $164 million in 2002. But this budg-
et plateaued in 2003 and is expected to
drop slightly in 2004. And spending of
hundreds of millions of dollars by agencies
such as the NIAID to fight perceived
bioterrorism threats such as smallpox bare-
ly addresses the wide range of potential
causes of natural outbreaks, says Epstein. 
Efforts so far are indeed limited and too
disease-specific, says Mark S. Smolinski,
study director for the IOM’s Microbial
Threats to Health and now a senior program
officer with the Nuclear Threat Initiative, a
privately funded advocacy organization.
“There’s no master plan,” he says. “It’s still
surprising to me that agencies within a sin-
gle department really don’t know what each
other is doing. There is no research agenda
in the United States for infectious disease.”
Just establishing an effective global surveil-
lance network is at least a decade or more
away, the NIC said in Global Infectious
Disease Threat. 
But even with careful observation, dis-
eases caused by naturally occurring microbes
can be difficult to spot until large outbreaks
occur, because identifying a true outbreak
amongst all the background noise of other
diseases requires an ideal confluence of very
observant medical personnel, a highly effec-
tive reporting network, and diligent data
analysts. And synthetic microbes, which
now can be created in a matter of weeks, add
to the potential for outbreaks if they escape
from their laboratories by accident or by
design. Furthermore, identifying outbreaks
doesn’t always help. Some countries don’t
report them, for economic, cultural, reli-
gious, or political reasons, as when China
initially withheld information about SARS
from the world for several months after the
disease first appeared. And the difficulty of
enforcing quarantines in relatively open
societies contributes to problems in control-
ling outbreaks once they are discovered. 
In addition, the medical tools needed to
fight outbreaks are limited. Vaccines often
take years to develop, and many antibiotics
are no longer effective, due to resistance
developed by microbes. For example, part
of the reason for the surge in malaria cases
is increasing resistance to drugs used to
treat it. In sub-Saharan Africa, infection
rates increased by 40% from 1970 to 1997,
the NIC reported in Global Infectious
Disease Threat, and in 80 of the 92
countries heavily affected by malar-
ia, the first-line drug treatment,
chloroquine, no longer works.
Alternatives can cost up to 33 times
as much as chloroquine [see “An
Affordable Antimalarial,” p. A25
this issue], and some can have more
side effects, take longer to cure, and
entail protocols that are more diffi-
cult for patients to comply with.
When outbreaks do occur, even
countries with the most advanced
medical facilities remain ill-pre-
pared to handle them. Canada did
well coping with its 2003 SARS
outbreak, but still the episode
“completely overwhelmed their
medical system,” Smolinski says. In
the United States, the medical sys-
tem would break down under simi-
lar pressures, the U.S. General
Accounting Office has said in sever-
al 2003 reports.
Those pressures likely will con-
tinue to surface around the
world—and sooner or latr they will
surface in the United States. “One
can safely predict that infectious
diseases will continue to emerge,
and that we will encounter unpleas-
ant surprises, as well as increases in
already worrisome trends,” the IOM con-
cluded in Microbial Threats to Health.
“Depending on present policies and
actions, this situation could lead to a cata-
strophic storm of microbial threats.” 
Although some steps are being taken to
fight emerging and re-emerging infectious
diseases, it likely will be a decade or more
before any substantial global structure for
coping with infectious diseases is in place,
said the NIC in Global Infectious Disease
Threat. In the interim and possibly beyond,
the NIC speculated, microbes will continue
their deadly hot streak.
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Lots left to learn. More funds are needed to understand and
combat pathogens such as (clockwise from top left) coronavirus,
Borrelia burgdorferi, HIV, and Plasmodium malariae.